日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rheumatic immune-related adverse effects of immune checkpoint treatment: a retrospective multicentre study

免疫检查点治疗的风湿性免疫相关不良反应:一项回顾性多中心研究

Llobell-Uriel, Arturo; González-Mazón, Íñigo; Gratacós, Jordi; Retamozo, Soledad; Secada-Gómez, Carmen; Martín-Gutiérrez, Adrian; García-Castaño, Almudena; Fernández-Morales, Luis; Gallardo-Diaz, Enrique; Berenguer-Llergo, Antoni; Del Estal-Jiménez, Jorge; Delgado-Rodríguez, Javier; Gómez-Centeno, Antonio; Segui-Palmer, Miguel Angel; Blanco, Ricardo; Calvet, Joan

Exercise and cancer: a position statement from the Spanish Society of Medical Oncology

运动与癌症:西班牙肿瘤内科学会的立场声明

Pollán, M; Casla-Barrio, S; Alfaro, J; Esteban, C; Segui-Palmer, M A; Lucia, A; Martín, M

Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab

ABP 980(曲妥珠单抗生物类似药)研发过程中的所有科学证据

Kolberg, Hans-Christian; Colleoni, Marco; Santi, Patricia; Demetriou, Georgia Savva; Segui-Palmer, Miguel Angel; Fujiwara, Yasuhiro; Hurvitz, Sara A; Hanes, Vladimir

New clinical trials regulation in Spain: analysis of royal decree 1090/2015

西班牙新的临床试验法规:对第1090/2015号皇家法令的分析

Martin Jimenez, M; Calvo Ferrandiz, A; Aparicio Urtasun, J; Garcia-Campelo, R; Gonzalez-Flores, E; Lazaro Quintela, M; Muñoz Mateu, M; Rodriguez Sanchez, C A; Santaballa Bertran, A; Sepulveda Sanchez, J M; Vera Garcia, R; Virizuela Echaburu, J A; Segui Palmer, M A

High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer

高增殖预示早期乳腺癌新辅助化疗后病理完全缓解

Alba, Emilio; Lluch, Ana; Ribelles, Nuria; Anton-Torres, Antonio; Sanchez-Rovira, Pedro; Albanell, Joan; Calvo, Lourdes; García-Asenjo, Jose Antonio Lopez; Palacios, Jose; Chacon, Jose Ignacio; Ruiz, Amparo; De la Haba-Rodriguez, Juan; Segui-Palmer, Miguel A; Cirauqui, Beatriz; Margeli, Mireia; Plazaola, Arrate; Barnadas, Agusti; Casas, Maribel; Caballero, Rosalia; Carrasco, Eva; Rojo, Federico